9966.HK
9966.HK
KYG0330A1013
ALPHAMAB-B
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 566.235.000 640.083.000
11.5%
Cost of Revenue 63.546.000 60.316.000
5.4%
Gross Profit 502.689.000 579.767.000
13.3%
638.461.000 465.991.000
37.0%
Operating Income -135.772.000 113.776.000
219.3%
Pretax Income -113.939.000 166.342.000
168.5%
Net Income Common Stockholders -113.939.000 166.342.000
168.5%
-- --
--
-- --
--
ende